ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 36 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,000 | -41.7% | 1,728 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | +33.3% | 1,728 | 0.0% | 0.00% | – |
| Q4 2018 | $9,000 | -52.6% | 1,728 | 0.0% | 0.00% | – |
| Q3 2018 | $19,000 | -17.4% | 1,728 | 0.0% | 0.00% | – |
| Q2 2018 | $23,000 | +130.0% | 1,728 | +88.2% | 0.00% | – |
| Q1 2018 | $10,000 | +11.1% | 918 | 0.0% | 0.00% | – |
| Q4 2017 | $9,000 | – | 918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $24,309,000 | 36.46% |
| Pharmstandard International S.A. | 873,031 | $9,376,000 | 32.28% |
| TRV GP II, LLC | 2,790,964 | $29,975,000 | 17.60% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $35,768,000 | 6.55% |
| Partner Investment Management, L.P. | 301,889 | $3,242,000 | 2.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 295,199 | $3,170,000 | 0.36% |
| PFM Health Sciences, LP | 1,768,568 | $18,994,000 | 0.28% |
| Perceptive Advisors | 250,000 | $2,685,000 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 4,616 | $200,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $894,000 | 0.01% |